Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 12,800 shares at $8.88 ($113K) on 2007-08-31, disclosed to the SEC on 2007-08-31.
Scheduled sale ($113k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.70 | 1,900 | $17K | 14.6% |
| 2 | $8.71 | 600 | $5K | 4.6% |
| 3 | $8.72 | 1,000 | $9K | 7.7% |
| 4 | $8.73 | 100 | $873 | 0.8% |
| 5 | $8.74 | 200 | $2K | 1.5% |
| 6 | $8.75 | 800 |
| $7K |
| 6.2% |
| 7 | $8.76 | 100 | $876 | 0.8% |
| 8 | $8.77 | 100 | $877 | 0.8% |
| 9 | $8.79 | 400 | $4K | 3.1% |
| 10 | $8.80 | 200 | $2K | 1.6% |
| 11 | $8.81 | 100 | $881 | 0.8% |
| 12 | $8.82 | 200 | $2K | 1.6% |
| 13 | $8.83 | 1,000 | $9K | 7.8% |
| 14 | $8.84 | 1,000 | $9K | 7.8% |
| 15 | $8.85 | 800 | $7K | 6.3% |
| 16 | $8.86 | 200 | $2K | 1.6% |
| 17 | $8.87 | 400 | $4K | 3.1% |
| 18 | $8.88 | 100 | $888 | 0.8% |
| 19 | $8.89 | 200 | $2K | 1.6% |
| 20 | $8.90 | 1,200 | $11K | 9.5% |
| 21 | $8.91 | 400 | $4K | 3.2% |
| 22 | $8.92 | 200 | $2K | 1.6% |
| 23 | $8.93 | 516 | $5K | 4.1% |
| 24 | $8.94 | 584 | $5K | 4.6% |
| 25 | $8.95 | 400 | $4K | 3.2% |
| 26 | $8.96 | 100 | $896 | 0.8% |
| Total | $8.82 avg | 12,800 | $113K | 100% |
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |